Max Health stock at INR 883.80, 27.7 percent below its 52-week high

Published on 10/09/2026 at 15:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Max Health stock was at INR 883.80 on October 9, 2026 versus INR 873.40. Market value was INR 860.2 billion and P/E stood at 59.3.

Key points in brief

Max Health stock was at INR 883.80 on October 9, 2026, up 1.19 percent from INR 873.40.
The price stood 27.7 percent below the INR 1,221.90 52-week high.
Market capitalization was INR 860.2 billion and P/E was 59.3.
Anand Rathi retained an INR 1,220 target in its August 17, 2026 update.

Max Health, INE027H01010, Illustration mit AI erstellt.

At 3:15 p.m. IST on October 9, 2026, Max Health stock was trading at INR 883.80, up 1.19 percent versus the prior close of INR 873.40. The price stood 27.7 percent below its 52-week high of INR 1,221.90, giving the session a clear valuation and range context.

Price remains below yearly high

The NSE quote was 1.01 percent above the INR 870.00 52-week low on the same date. Trading volume reached 5,377,032 shares, compared with an average volume of 2,150,039 shares.

Max Health's market capitalization was INR 860.2 billion on October 9, 2026. Its P/E ratio stood at 59.3, while the 52-week range extended from INR 870.00 to INR 1,221.90.

Comparison with peers

Max Health (NSE, INR): plus 1.19 percent, P/E 59.3, market capitalization INR 860.2 billion
Apollo Hospitals (NSE, INR): plus 4.72 percent, P/E 55.2, market capitalization INR 1,154.2 billion
Fortis Healthcare (NSE, INR): plus 3.05 percent, P/E 56.7, market capitalization INR 593.6 billion

Analyst target stays higher

DSIJ reported on August 17, 2026 that Anand Rathi Research retained its BUY recommendation and INR 1,220 target. The target lies 38.05 percent above the INR 883.80 price, calculated in the same currency.

The same report said Max Healthcare generated INR 28.35 billion of consolidated revenue in the first quarter of fiscal 2027, up 15.2 percent year over year. Adjusted net profit reached INR 3.79 billion, up 3.3 percent year over year, while EBITDA rose 14.8 percent to INR 7.05 billion.

Market position on October 9

The price report places Max Health below its yearly high while its market value remains between the larger Apollo Hospitals and smaller Fortis Healthcare. The comparison also shows that Max Health's P/E of 59.3 was higher than both peers at the quoted time.

Market context: Market report BSE Sensex.